THC

Tenet Healthcare Corporation
NYSEHEALTHCAREMEDICAL CARE FACILITIES

Key Statistics

Market Cap
$21.30B
P/E Ratio
10.22
EPS
$25.88
Beta
1.23
52W High
$270.57
52W Low
$157.58
50-Day MA
$209.11
200-Day MA
$203.23
Dividend Yield
Profit Margin
10.30%
Forward P/E
13.39
PEG Ratio
1.94

About Tenet Healthcare Corporation

Tenet Healthcare Corporation is a diversified health services company. The company is headquartered in Dallas, Texas.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$21.81B
Gross Profit (TTM)$9.09B
EBITDA$4.84B
Operating Margin18.20%
Return on Equity37.30%
Return on Assets8.32%
Revenue/Share (TTM)$252.49
Book Value$57.86
Price-to-Book4.63
Price-to-Sales (TTM)0.98
EV/Revenue1.442
EV/EBITDA5.85
Quarterly Earnings Growth (YoY)213.40%
Quarterly Revenue Growth (YoY)6.80%
Shares Outstanding$80.52M
Float$79.54M
% Insiders1.13%
% Institutions102.63%

Historical Volatility

HV 10-Day
27.89%
HV 20-Day
65.91%
HV 30-Day
62.83%
HV 60-Day
53.89%
HV Rank
94.8%

Volatility is currently contracting

Analyst Ratings

Consensus ($282.00 target)
5
Strong Buy
14
Buy
3
Hold

Latest News

Are Investors Undervaluing Tenet Healthcare (THC) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research8/14/2026Positive
Tenet Healthcare (THC) Just Flashed Golden Cross Signal: Do You Buy?

Tenet Healthcare Corporation (THC) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, THC's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.

Zacks Investment Research8/11/2026Positive
Is It Worth Investing in Tenet (THC) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks Investment Research8/4/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on THC and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 8/18/2026